ATP-binding cassette G5/G8 deficiency causes hypertriglyceridemia by affecting multiple metabolic pathways


Por: Méndez-González J., Julve J., Rotllan N., Llaverias G., Blanco-Vaca F., Escolà-Gil J.C.

Publicada: 1 ene 2011
Resumen:
Mutations in ABCG5 or ABCG8 transporters are responsible for sitosterolemia, an autosomal recessive disease characterized by the accumulation of plant sterols. The aim of this study was to investigate the effects of ABCG5 and ABCG8 deficiency on TG metabolism in mice. Experiments were carried out in wild-type (G5/G8+/+) mice, mice heterozygous for ABCG5 and ABCG8 deficiency (G5/G8+/-) and ABCG5/G8-deficient (G5/G8-/-) mice fed a chow diet. Plasma TG were 2.6 and 4.3-fold higher in fasted G5/G8+/- and G5/G8-/- mice, respectively, than in G5/G8+/+ mice. Postprandial TG were 5-fold higher in G5/G8-/- mice. TG metabolism studies indicate that: first, the fractional catabolic rate was significantly lower in G5/G8+/- (1.3-fold) and G5/G8-/- mice (1.5-fold) compared to G5/G8+/+ and postheparin plasma lipoprotein lipase activities were significantly lower in G5/G8+/- (1.8-fold) and G5/G8-/- mice (5.4-fold) than in G5/G8+/+. Second, liver TG secretion was 1.3-fold higher in G5/G8+/- and G5/G8-/- than in G5/G8+/+ mice and this was associated with an increase in liver LXR, FAS, ACAC and CD36 gene expression. Third, TG intestinal secretion, determined after an oral fat gavage of glycerol tri[9,10(n)-3H] oleate, was 5.8-fold higher in G5/G8-/- than in G5/G8+/+ mice. Also, the HOMA index was 2.6-fold higher in G5/G8-/- than in G5/G8+/+ mice, reflecting a degree of insulin resistance. In conclusion, ABCG5/G8 deficiency in mice fed a chow diet markedly raises TG levels by impairing TG catabolism and by increasing liver and intestinal TG secretion. © 2011 Elsevier B.V. All rights reserved.

Filiaciones:
Méndez-González J.:
 IIB Sant Pau, 08025 Barcelona, Spain

 Servei de Bioquímica, Hospital de la Santa Creu i Sant Pau, Antoni M.Claret 167, 08025 Barcelona, Spain

 Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, 08025 Barcelona, Spain

Julve J.:
 IIB Sant Pau, 08025 Barcelona, Spain

 CIBER de Diabetes y Enfermedades Metabólicas Asociadas, CIBERDEM, Spain

Rotllan N.:
 IIB Sant Pau, 08025 Barcelona, Spain

Llaverias G.:
 IIB Sant Pau, 08025 Barcelona, Spain

Blanco-Vaca F.:
 IIB Sant Pau, 08025 Barcelona, Spain

 Servei de Bioquímica, Hospital de la Santa Creu i Sant Pau, Antoni M.Claret 167, 08025 Barcelona, Spain

 Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, 08025 Barcelona, Spain

 CIBER de Diabetes y Enfermedades Metabólicas Asociadas, CIBERDEM, Spain

Escolà-Gil J.C.:
 IIB Sant Pau, 08025 Barcelona, Spain

 CIBER de Diabetes y Enfermedades Metabólicas Asociadas, CIBERDEM, Spain
ISSN: 13881981
Editorial
ELSEVIER, RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, Países Bajos
Tipo de documento: Article
Volumen: 1811 Número: 12
Páginas: 1186-1193
WOS Id: 000298521700021
ID de PubMed: 21855652

MÉTRICAS